| Trial ID: | L2693 |
| Source ID: | NCT00398892
|
| Associated Drug: |
Lipoic Acid
|
| Title: |
The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Lipoic acid
|
| Outcome Measures: |
Primary: HbA1c change for lipoic acid vs placebo, 12 weeks | Secondary: Urine ACR change for lipoic acid vs placebo, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Edinburgh | Collaborators: NHS Lothian
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-12
|
| Completion Date: |
2011-01
|
| Results First Posted: |
|
| Last Update Posted: |
2024-05-29
|
| Locations: |
Diabetes Department, St John's Hospital, Livingston, Scotland, EH54 6PP, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00398892
|
